Institutional Ownership
Atai Life Sciences NV
CUSIP N0731H103SHSQ1 2026
13D / 13G Filings
5
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
20.1%
Max % of class reported
Institutional Holders
6
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
5 filings · latest May 27, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | May 27, 2025 | Galaxy Group Funding Eci U LLC | 13G/A | 4.2% | 8.47M | SEC |
| 2 | Feb 13, 2024 | Apeiron Investment Group Ltd. | 13G/A | 20.1% | 33.89M | SEC |
| 3 | Feb 10, 2023 | Apeiron Investment Group Ltd. | 13G/A | 19.4% | 32.67M | SEC |
| 4 | Mar 1, 2022 | Galaxy Group Funding Eci U LLC | 13G | 6.7% | 10.80M | SEC |
| 5 | Feb 10, 2022 | Apeiron Investment Group Ltd. | 13G | 19.7% | 32.06M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Brown University | 718.5K | $2.54M |
| 2 | Stableford Capital II LLC | 286.3K | $1.01M |
| 3 | Klp Kapitalforvaltning As | 69.8K | $247.1K |
| 4 | Wealth Enhancement Advisory Services, LLC | 52.4K | $198.8K |
| 5 | Rhl Group, LLC | 72 | $255 |
| 6 | Sankala Group LLC | 52 | $177 |